AAAAAA

   
Results: 1-11 |
Results: 11
Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease
Authors: Zanon, E Vianello, F Casonato, A Girolami, A
Citation: E. Zanon et al., Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease, HAEMOPHILIA, 7(5), 2001, pp. 500-503
Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding
Authors: Casonato, A Pontara, E Vertolli, UP Steffan, A Durante, C De Marco, L Sartorello, F Girolami, A
Citation: A. Casonato et al., Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding, CL APPL T-H, 7(2), 2001, pp. 81-86
Combined hemophilia A and type 2N von Willebrand's disease: defect of bothfactor VIII level and factor VIII binding capacity of von Willebrand factor
Authors: Casonato, A Pontara, E Sartorello, F Gemmati, D Cattini, MG Girolami, A
Citation: A. Casonato et al., Combined hemophilia A and type 2N von Willebrand's disease: defect of bothfactor VIII level and factor VIII binding capacity of von Willebrand factor, HAEMATOLOG, 86(10), 2001, pp. 1110-1111
Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization
Authors: Casonato, A Pontara, E Sartorello, F Bertomoro, A Durante, C Girolami, A
Citation: A. Casonato et al., Type 2M von Willebrand disease variant characterized by abnormal von Willebrand factor multimerization, J LA CL MED, 137(1), 2001, pp. 70-76
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?
Authors: Casonato, A Pontara, E Bertomoro, A Sartorello, F Cattini, MG Girolami, A
Citation: A. Casonato et al., Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?, BR J HAEM, 112(3), 2001, pp. 578-583
Adrenaline potentiates type 2B von Willebrand factor-induced activation ofhuman platelets by enhancing both the formation and action of thromboxanes
Authors: Francesconi, M Scapin, M Casonato, A Girolami, A Deana, R
Citation: M. Francesconi et al., Adrenaline potentiates type 2B von Willebrand factor-induced activation ofhuman platelets by enhancing both the formation and action of thromboxanes, THROMB RES, 100(4), 2000, pp. 293-303
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects bymeans of carotid echo-color Doppler scan
Authors: Bilora, F Dei Rossi, C Girolami, B Casonato, A Zanon, E Bertomoro, A Girolami, A
Citation: F. Bilora et al., Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects bymeans of carotid echo-color Doppler scan, CL APPL T-H, 5(4), 1999, pp. 232-235
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome
Authors: Casonato, A Pontara, E Boscaro, M Sonino, N Sartorello, F Ferasin, S Girolami, A
Citation: A. Casonato et al., Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome, BL COAG FIB, 10(3), 1999, pp. 145-151
Which assay is the most suitable to investigate von Willebrand factor functional activity?
Authors: Casonato, A Pontara, E Bertomoro, A Sartorello, F Girolami, A
Citation: A. Casonato et al., Which assay is the most suitable to investigate von Willebrand factor functional activity?, THROMB HAEM, 81(6), 1999, pp. 994-995
Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: Failure to demonstrate glycocalicin increase or platelet activation
Authors: Casonato, A Steffan, A Pontara, E Zucchetto, A Rossi, C De Marco, L Girolami, A
Citation: A. Casonato et al., Post-DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: Failure to demonstrate glycocalicin increase or platelet activation, THROMB HAEM, 81(2), 1999, pp. 224-228
Two novel mutations (Pro864His, Va1867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28
Authors: Bernardi, F Casonato, A Marchetti, G Gemmati, D Bizzaro, N Pontara, E Girolami, A
Citation: F. Bernardi et al., Two novel mutations (Pro864His, Va1867Glu) causing type 2A von Willebrand disease and affecting a single restriction site in exon 28, BR J HAEM, 103(3), 1998, pp. 885-887
Risultati: 1-11 |